ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 113 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $628,500 | +452.2% | 203,398 | +361.0% | 0.00% | – |
Q1 2024 | $113,827 | -52.8% | 44,119 | -54.3% | 0.00% | – |
Q4 2023 | $241,272 | -41.6% | 96,509 | -29.2% | 0.00% | – |
Q1 2023 | $412,952 | +66.3% | 136,288 | +27.9% | 0.00% | – |
Q4 2022 | $248,253 | +589.6% | 106,546 | +464.7% | 0.00% | – |
Q3 2022 | $36,000 | -68.7% | 18,869 | -55.7% | 0.00% | – |
Q2 2022 | $115,000 | -91.1% | 42,601 | -90.2% | 0.00% | – |
Q1 2022 | $1,296,000 | -60.6% | 434,714 | -48.6% | 0.00% | – |
Q4 2021 | $3,293,000 | +66.6% | 846,380 | +83.7% | 0.00% | – |
Q3 2021 | $1,977,000 | +924.4% | 460,861 | +624.2% | 0.00% | – |
Q2 2021 | $193,000 | -63.8% | 63,635 | -60.3% | 0.00% | – |
Q1 2021 | $533,000 | -45.1% | 160,362 | -41.4% | 0.00% | – |
Q4 2020 | $971,000 | +1732.1% | 273,464 | +1525.3% | 0.00% | – |
Q3 2020 | $53,000 | -72.7% | 16,825 | -84.2% | 0.00% | – |
Q2 2020 | $194,000 | +165.8% | 106,181 | +45.6% | 0.00% | – |
Q1 2020 | $73,000 | -79.0% | 72,925 | -56.4% | 0.00% | -100.0% |
Q2 2019 | $348,000 | +411.8% | 167,188 | +1422.2% | 0.00% | – |
Q3 2017 | $68,000 | -56.1% | 10,983 | -56.7% | 0.00% | -100.0% |
Q3 2015 | $155,000 | – | 25,374 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,651,825 | $19,358,000 | 6.60% |
RTW INVESTMENTS, LP | 5,165,499 | $37,708,000 | 2.72% |
Eversept Partners, LP | 97,495 | $711,714 | 0.33% |
Seelaus Asset Management LLC | 14,300 | $104,000 | 0.09% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,315 | $8,827,000 | 0.08% |
ALGERT GLOBAL LLC | 34,816 | $254,000 | 0.05% |
BOOTHBAY FUND MANAGEMENT, LLC | 48,000 | $350,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 211,115 | $1,540,000 | 0.03% |
PRIMECAP MANAGEMENT CO/CA/ | 4,000,400 | $29,203,000 | 0.02% |
PDT Partners, LLC | 66,965 | $489,000 | 0.02% |